- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/00 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 249/00
Total number of patents in this class: 70
10-year publication summary
|
2
|
3
|
3
|
2
|
2
|
3
|
4
|
6
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4729 |
9 |
| The Regents of the University of California | 20720 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Bayer Cropscience AG | 1846 |
2 |
| ChemoCentryx, Inc. | 361 |
2 |
| Dipharma Francis S.r.l. | 50 |
2 |
| Rigel Pharmaceuticals, Inc. | 507 |
2 |
| Synta Pharmaceuticals Corp. | 146 |
2 |
| Merck Sharp & Dohme LLC | 3735 |
2 |
| Hoffmann-La Roche Inc. | 3783 |
1 |
| Amgen Inc. | 4425 |
1 |
| BASF AG | 123 |
1 |
| Konica Minolta Business Technologies, Inc. | 1320 |
1 |
| Siemens Medical Solutions USA, Inc. | 1465 |
1 |
| The General Hospital Corporation | 4858 |
1 |
| President and Fellows of Harvard College | 6091 |
1 |
| The Board of Trustees of the University of Illinois | 2750 |
1 |
| Aerojet-general Corporation | 17 |
1 |
| Albert Einstein College of Medicine, Inc. | 595 |
1 |
| Ardea Biosciences, Inc. | 68 |
1 |
| Other owners | 34 |